Merck Annual Report 2010 - Sitemap (optimized for printing)

Merck 2010 at a glance
- Development 2001-2010
- Key events of 2010
- About Merck
  - History
  - Today and the future
- Letter from Karl-Ludwig Kley
- Executive Board
- Financial calendar
Corporate governance
- Corporate governance report
  - Merck KGaA
  - Compensation report
    - Executive Board
    - Supervisory Board
    - Ownership of shares
- Corporate governance practices
  - Principles
  - Values and compliance
- Procedures of the corporate bodies
  - Executive Board
  - Supervisory Board
  - Board of Partners of E. Merck OHG
- Report of the Supervisory Board
- Objectives of the supervisory board
Merck in the capital market
- Share price development
- Share data
- Shareholder structure
- Estimates
- Capital and shares
- Bond issue
Management Report
- Economic situation
- Financial position and results of operations
  - Business development
  - Business sectors
  - Regions
  - Acquisitions
  - Total assets
  - Free cash flow
  - Capital spending
  - Key financial performance indicators
  - Value added
- Corporate Responsibility
  - Employees
  - International human resources work
  - Diversity in the workforce
  - Products and the environment
  - Society
- Corporate and Other
- Risk report
  - Business-related risks
  - Financial risks
  - Legal risks
  - Human resource risks
  - Information technology risks
  - Environmental and safety risks
- Report on expected developments
  - Global economy
  - Merck
  - Pharmaceuticals
  - Chemicals
- Subsequent events
Merck Serono
- Business development
- Regions
- Therapeutic areas
  - Oncology
  - Neurodegenerative Diseases
  - Fertility
  - Endocrinology
  - CardioMetabolic Care and General Medicine
- Research and development
  - Overview compounds
  - Cooperations
  - Oncology
  - Neurodegenerative Diseases
  - Fertility
  - Autoimmune and Inflammatory Diseases
  - Endocrinology
Consumer Health Care
- Business development
- Brands
- Regions
Merck Millipore
- Business development
- Bioscience
- Lab Solutions
- Process Solutions
Performance Materials
- Business development
- Liquid Crystals
- Pigments / Cosmetics
Financial Statements
- Income Statement
- Balance Sheet
- Segment Reporting
  - Divisions
  - Regions
- Cash Flow Statement
- Free Cash Flow
- Comprehensive Income
- Changes in Net Equity
Notes
- Scope of consolidation
- Accounting policies
- Notes to the
  income statement
  - Sales
  - Royalty, license and commission income
  - Cost of sales
  - Marketing and selling expenses
  - Royalty, license and commission expenses
  - Administration expenses
  - Other operating expenses and income
  - Research and development
  - Amortization of intangible assets
  - Investment result
  - Exceptional items
  - Financial result
  - Income tax
  - Non-controlling interest
  - Earnings per share
- Notes to the balance sheet
  - Cash and cash equivalents
  - Marketable securities
  - Trade accounts receivable
  - Inventories
  - Other assets
  - Tax receivables
  - Assets held for sale and liabilites
  - Intangible assets
  - Property, plant and equipment
  - Investments at equity
  - Non-current financial assets
  - Financial assets covering pension obligations
  - Financial liabilities
  - Trade accounts payable
  - Other liabilities
  - Tax liabilities
  - Provisions
  - Provisions for pensions
  - Net equity
- Notes to the segment reporting
- Notes to the cash flow statement
  - Net cash flows from operating activities
  - Net cash flows from investing activities
  - Net cash flows from financing activities
  - Cash and cash equivalents
  - Free cash flow
- Other disclosures
  - Derivative financial instruments
  - Management of financial risks
  - Other disclosures on financial instruments
  - Contingent liabilities
  - Other financial obligations
  - Personnel expenses
  - Material costs
  - Auditors' fees
  - Corporate governance
  - Companies opting for exemption
  - Related-party disclosures
  - Compensation of the corporate bodies
  - Preparation and approval
  - Subsequent events
  - List of shareholdings
- Auditor's Report